[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Heart Failure on In-Hospital Outcomes in Tumor Lysis Syndrome: A National Inpatient Sample Analysis",
    "section": "",
    "text": "Study Objective: The primary objective of this study was to evaluate and assess the impact of heart failure on outcomes in tumor lysis syndrome, using a nationally representative inpatient database.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2021. The NIS is part of the Healthcare Cost and Utilization Project (HCUP) and provides a stratified sample of inpatient discharges from U.S. community hospitals across all payers.\nCohort Definition: Patients were included if they met the following criteria\n\nAge ≥ 18 years\nHad a diagnosis of tumor lysis syndrome (ICD 10:E88.3)\nInformation for HF (ICD 10: I50) was not missing\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2021 ($)\n\nSecondary Outcomes:\n\nAcute kidney injury\nPatient requiring renal replacement therapy\nRespiratory failure\nPatient requiring mechanical ventilation\nSepsis\nCardiac arrhythmia\nNon-home discharge\nFluid and electrolyte imbalance\nHyperkalemia\n\nCovariates for Adjustment: All models were adjusted for the following:\n\nDemographics: Age, sex, race, income, weekend admission, type of admission (elective/non-elective), insurance, location of patient’s residence, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Type of cancer, hypertension, diabetes mellitus, chronic kidney disease, peripheral vascular disease, chronic pulmonary disease, anemia, liver disease, and obesity.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Heart Failure on In-Hospital Outcomes in Tumor Lysis Syndrome: A National Inpatient Sample Analysis",
    "section": "",
    "text": "Study Objective: The primary objective of this study was to evaluate and assess the impact of heart failure on outcomes in tumor lysis syndrome, using a nationally representative inpatient database.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2021. The NIS is part of the Healthcare Cost and Utilization Project (HCUP) and provides a stratified sample of inpatient discharges from U.S. community hospitals across all payers.\nCohort Definition: Patients were included if they met the following criteria\n\nAge ≥ 18 years\nHad a diagnosis of tumor lysis syndrome (ICD 10:E88.3)\nInformation for HF (ICD 10: I50) was not missing\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2021 ($)\n\nSecondary Outcomes:\n\nAcute kidney injury\nPatient requiring renal replacement therapy\nRespiratory failure\nPatient requiring mechanical ventilation\nSepsis\nCardiac arrhythmia\nNon-home discharge\nFluid and electrolyte imbalance\nHyperkalemia\n\nCovariates for Adjustment: All models were adjusted for the following:\n\nDemographics: Age, sex, race, income, weekend admission, type of admission (elective/non-elective), insurance, location of patient’s residence, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Type of cancer, hypertension, diabetes mellitus, chronic kidney disease, peripheral vascular disease, chronic pulmonary disease, anemia, liver disease, and obesity.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#descriptive-analysis",
    "href": "quarto/index.html#descriptive-analysis",
    "title": "Impact of Heart Failure on In-Hospital Outcomes in Tumor Lysis Syndrome: A National Inpatient Sample Analysis",
    "section": "Descriptive analysis",
    "text": "Descriptive analysis\n\nBaseline Characteristics:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWithout heart failure\nN = 49,9251\nWith heart failure\nN = 11,7801\np-value2\n\n\n\n\nAge, y\n65 (54, 73)\n71 (63, 78)\n&lt;0.001\n\n\nSex\n\n\n\n\n0.6\n\n\n    Female\n18,540 (37%)\n4,440 (38%)\n\n\n\n\n    Male\n31,380 (63%)\n7,340 (62%)\n\n\n\n\nRace\n\n\n\n\n&lt;0.001\n\n\n    White\n32,785 (67%)\n8,085 (70%)\n\n\n\n\n    Black\n6,755 (14%)\n1,960 (17%)\n\n\n\n\n    Hispanic\n5,230 (11%)\n780 (6.8%)\n\n\n\n\n    Other\n3,815 (7.9%)\n660 (5.7%)\n\n\n\n\nType of Cancer\n\n\n\n\n&lt;0.001\n\n\n    Solid Tumors\n27,830 (56%)\n5,720 (49%)\n\n\n\n\n    Acute Lymphoblastic Leukemia\n6,810 (14%)\n2,175 (18%)\n\n\n\n\n    Acute Myeloid Leukemia\n3,580 (7.2%)\n345 (2.9%)\n\n\n\n\n    Chronic Lymphocytic Leukemia\n2,600 (5.2%)\n870 (7.4%)\n\n\n\n\n    Chronic Myeloid Leukemia\n1,550 (3.1%)\n355 (3.0%)\n\n\n\n\n    Multilpe Myeloma\n2,745 (5.5%)\n920 (7.8%)\n\n\n\n\n    Other\n4,810 (9.6%)\n1,395 (12%)\n\n\n\n\nWeekend Admission\n\n\n\n\n0.10\n\n\n    Monday-Friday\n40,470 (81%)\n9,375 (80%)\n\n\n\n\n    Saturday-Sunday\n9,455 (19%)\n2,405 (20%)\n\n\n\n\nType of admission\n\n\n\n\n&lt;0.001\n\n\n    Elective\n6,245 (13%)\n1,045 (8.9%)\n\n\n\n\n    Non-elective\n43,620 (87%)\n10,690 (91%)\n\n\n\n\nResidential income\n\n\n\n\n0.11\n\n\n    $1 - $51,999\n12,605 (26%)\n3,240 (28%)\n\n\n\n\n    $52,000 - $65,999\n12,290 (25%)\n2,895 (25%)\n\n\n\n\n    $66,000 - $87,999\n12,385 (25%)\n2,755 (24%)\n\n\n\n\n    $88,000 or more\n11,870 (24%)\n2,675 (23%)\n\n\n\n\nExpected primary payer\n\n\n\n\n&lt;0.001\n\n\n    Private\n17,475 (35%)\n2,420 (21%)\n\n\n\n\n    Medicaid\n6,730 (13%)\n980 (8.3%)\n\n\n\n\n    Medicare\n24,235 (49%)\n8,085 (69%)\n\n\n\n\n    Other\n1,445 (2.9%)\n280 (2.4%)\n\n\n\n\nHospital region\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n10,985 (22%)\n3,050 (26%)\n\n\n\n\n    Northeast\n9,885 (20%)\n2,585 (22%)\n\n\n\n\n    South\n17,630 (35%)\n4,010 (34%)\n\n\n\n\n    West\n11,425 (23%)\n2,135 (18%)\n\n\n\n\nHospital bedsize\n\n\n\n\n0.007\n\n\n    Large\n33,815 (68%)\n7,660 (65%)\n\n\n\n\n    Medium\n10,150 (20%)\n2,750 (23%)\n\n\n\n\n    Small\n5,960 (12%)\n1,370 (12%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n0.060\n\n\n    Rural\n1,155 (2.3%)\n270 (2.3%)\n\n\n\n\n    Urban, non-teaching\n4,015 (8.0%)\n1,120 (9.5%)\n\n\n\n\n    Urban, teaching\n44,755 (90%)\n10,390 (88%)\n\n\n\n\nDiabetes mellitus\n7,615 (15%)\n2,190 (19%)\n&lt;0.001\n\n\nHypertension\n9,215 (18%)\n265 (2.2%)\n&lt;0.001\n\n\nChronic kidney disease\n11,410 (23%)\n5,035 (43%)\n&lt;0.001\n\n\nPeripheral vascular disease\n2,120 (4.2%)\n1,205 (10%)\n&lt;0.001\n\n\nChronic pulmonary disease\n7,280 (15%)\n2,840 (24%)\n&lt;0.001\n\n\nLiver disease\n6,330 (13%)\n1,545 (13%)\n0.6\n\n\nAnemia\n34,690 (69%)\n8,395 (71%)\n0.10\n\n\nObesity\n6,295 (13%)\n2,000 (17%)\n&lt;0.001\n\n\n\n1 Median (Q1, Q3); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\nOutcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWithout heart failure\nN = 49,9251\nWith heart failure\nN = 11,7801\np-value2\n\n\n\n\nDied during hospitalization\n11,290 (23%)\n3,455 (29%)\n&lt;0.001\n\n\nLength of stay (days)\n9 (4, 18)\n10 (5, 18)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n130,595 (63,630, 275,467)\n139,461 (69,204, 287,169)\n0.011\n\n\nAcute kidney injury\n34,020 (68%)\n9,495 (81%)\n&lt;0.001\n\n\nPatient requiring renal replacement therapy\n6,585 (13%)\n2,090 (18%)\n&lt;0.001\n\n\nSepsis\n13,330 (27%)\n3,840 (33%)\n&lt;0.001\n\n\nPatient requiring mechanical ventilation\n7,360 (15%)\n2,210 (19%)\n&lt;0.001\n\n\nRespiratory failure\n15,175 (30%)\n5,935 (50%)\n&lt;0.001\n\n\nNon-home discharge\n19,995 (40%)\n6,055 (51%)\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n36,785 (74%)\n9,125 (77%)\n&lt;0.001\n\n\nHyperkalemia\n14,525 (29%)\n3,840 (33%)\n0.001\n\n\nCardiac arrhythmia\n9,680 (19%)\n5,510 (47%)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of Heart Failure on In-Hospital Outcomes in Tumor Lysis Syndrome: A National Inpatient Sample Analysis",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nIn-hospital mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n1.40\n1.23, 1.58\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.94\n0.86, 1.04\n0.2\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.25\n1.09, 1.44\n0.002\n\n\n    Hispanic\n0.86\n0.72, 1.02\n0.077\n\n\n    Other\n1.24\n1.05, 1.46\n0.012\n\n\nAge, y\n1.01\n1.01, 1.01\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.00\n0.88, 1.13\n&gt;0.9\n\n\n    $66,000 - $87,999\n0.97\n0.85, 1.10\n0.6\n\n\n    $88,000 or more\n1.01\n0.89, 1.14\n&gt;0.9\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.01\n0.87, 1.18\n0.9\n\n\n    Medicare\n0.94\n0.83, 1.06\n0.3\n\n\n    Other\n1.39\n1.08, 1.79\n0.010\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.35\n1.21, 1.51\n&lt;0.001\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n2.12\n1.80, 2.50\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.21\n1.05, 1.38\n0.007\n\n\n    South\n0.98\n0.86, 1.10\n0.7\n\n\n    West\n0.98\n0.85, 1.12\n0.8\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.04\n0.93, 1.16\n0.5\n\n\n    Small\n0.82\n0.71, 0.95\n0.006\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.06\n0.75, 1.51\n0.7\n\n\n    Urban, teaching\n1.20\n0.87, 1.65\n0.3\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n1.13\n1.00, 1.27\n0.055\n\n\n    Acute Myeloid Leukemia\n0.48\n0.38, 0.61\n&lt;0.001\n\n\n    Chronic Lymphocytic Leukemia\n0.60\n0.48, 0.75\n&lt;0.001\n\n\n    Chronic Myeloid Leukemia\n0.61\n0.45, 0.82\n&lt;0.001\n\n\n    Multilpe Myeloma\n0.52\n0.42, 0.66\n&lt;0.001\n\n\n    Other\n0.98\n0.85, 1.14\n0.8\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.10\n0.93, 1.30\n0.3\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.87\n0.76, 0.99\n0.029\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.71, 0.93\n0.002\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.10\n0.91, 1.32\n0.3\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.87, 1.11\n0.8\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.17\n2.82, 3.55\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.70, 0.85\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.70, 0.92\n0.002\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nMechanical Ventilation:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n1.43\n1.23, 1.65\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.04\n0.93, 1.16\n0.5\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.29\n1.10, 1.50\n0.001\n\n\n    Hispanic\n0.98\n0.81, 1.18\n0.8\n\n\n    Other\n1.36\n1.12, 1.64\n0.002\n\n\nAge, y\n0.99\n0.99, 1.00\n0.004\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.97\n0.84, 1.12\n0.7\n\n\n    $66,000 - $87,999\n0.93\n0.80, 1.08\n0.3\n\n\n    $88,000 or more\n0.96\n0.82, 1.12\n0.6\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.07\n0.91, 1.26\n0.4\n\n\n    Medicare\n0.96\n0.84, 1.11\n0.6\n\n\n    Other\n0.96\n0.70, 1.33\n0.8\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.48\n1.31, 1.67\n&lt;0.001\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n1.84\n1.51, 2.25\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.96\n0.82, 1.12\n0.6\n\n\n    South\n0.89\n0.77, 1.03\n0.12\n\n\n    West\n0.84\n0.71, 0.98\n0.031\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.97\n0.85, 1.10\n0.6\n\n\n    Small\n0.68\n0.57, 0.82\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.90\n1.06, 3.41\n0.031\n\n\n    Urban, teaching\n2.24\n1.29, 3.89\n0.004\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.19\n0.96, 1.46\n0.11\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.81, 1.09\n0.4\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.76\n0.64, 0.89\n0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n0.83, 1.28\n0.8\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.26\n1.11, 1.44\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.74\n2.41, 3.12\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.97, 1.22\n0.2\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.83, 1.13\n0.7\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nRespiratory Failure:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n2.24\n2.01, 2.49\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.95\n0.87, 1.04\n0.3\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.00\n0.88, 1.13\n&gt;0.9\n\n\n    Hispanic\n0.88\n0.76, 1.02\n0.10\n\n\n    Other\n1.08\n0.93, 1.27\n0.3\n\n\nAge, y\n1.00\n1.00, 1.01\n0.3\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.96\n0.86, 1.08\n0.5\n\n\n    $66,000 - $87,999\n0.92\n0.82, 1.04\n0.2\n\n\n    $88,000 or more\n0.96\n0.85, 1.09\n0.6\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.02\n0.89, 1.18\n0.8\n\n\n    Medicare\n1.09\n0.97, 1.21\n0.14\n\n\n    Other\n1.27\n1.00, 1.62\n0.052\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.48\n1.34, 1.63\n&lt;0.001\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n2.28\n1.96, 2.65\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.89\n0.79, 1.02\n0.089\n\n\n    South\n0.92\n0.81, 1.03\n0.2\n\n\n    West\n0.94\n0.82, 1.08\n0.4\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.96\n0.87, 1.06\n0.4\n\n\n    Small\n0.89\n0.78, 1.02\n0.083\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.56\n1.13, 2.17\n0.007\n\n\n    Urban, teaching\n1.66\n1.23, 2.23\n&lt;0.001\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n1.18\n1.05, 1.32\n0.005\n\n\n    Acute Myeloid Leukemia\n0.50\n0.41, 0.61\n&lt;0.001\n\n\n    Chronic Lymphocytic Leukemia\n0.76\n0.64, 0.91\n0.003\n\n\n    Chronic Myeloid Leukemia\n0.93\n0.74, 1.18\n0.6\n\n\n    Multilpe Myeloma\n0.60\n0.50, 0.73\n&lt;0.001\n\n\n    Other\n1.15\n1.01, 1.32\n0.033\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n0.91, 1.23\n0.5\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.82, 1.04\n0.2\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.87\n0.77, 0.98\n0.023\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.78, 1.09\n0.4\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.68\n1.50, 1.87\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.90\n1.69, 2.15\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.15\n1.05, 1.26\n0.002\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.88, 1.12\n&gt;0.9\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nSepsis:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n1.42\n1.26, 1.60\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.95\n0.87, 1.04\n0.3\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.26\n1.11, 1.43\n&lt;0.001\n\n\n    Hispanic\n1.24\n1.07, 1.44\n0.004\n\n\n    Other\n1.31\n1.12, 1.53\n&lt;0.001\n\n\nAge, y\n1.00\n0.99, 1.00\n0.10\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.95\n0.85, 1.07\n0.4\n\n\n    $66,000 - $87,999\n0.92\n0.81, 1.03\n0.14\n\n\n    $88,000 or more\n0.98\n0.87, 1.11\n0.8\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.07\n0.93, 1.22\n0.4\n\n\n    Medicare\n0.97\n0.86, 1.09\n0.6\n\n\n    Other\n1.02\n0.80, 1.31\n0.8\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.32\n1.19, 1.46\n&lt;0.001\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n2.10\n1.77, 2.49\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.08\n0.93, 1.24\n0.3\n\n\n    South\n1.07\n0.94, 1.21\n0.3\n\n\n    West\n1.12\n0.97, 1.28\n0.11\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.03\n0.93, 1.15\n0.6\n\n\n    Small\n0.91\n0.79, 1.05\n0.2\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.41\n1.01, 1.98\n0.045\n\n\n    Urban, teaching\n1.33\n0.98, 1.81\n0.068\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n1.17\n1.04, 1.32\n0.011\n\n\n    Acute Myeloid Leukemia\n0.70\n0.58, 0.85\n&lt;0.001\n\n\n    Chronic Lymphocytic Leukemia\n0.81\n0.67, 0.99\n0.040\n\n\n    Chronic Myeloid Leukemia\n0.57\n0.43, 0.75\n&lt;0.001\n\n\n    Multilpe Myeloma\n0.70\n0.57, 0.85\n&lt;0.001\n\n\n    Other\n0.93\n0.81, 1.07\n0.3\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.13\n0.97, 1.32\n0.13\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.87, 1.09\n0.6\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.79, 1.03\n0.14\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.79, 1.15\n0.6\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.87, 1.09\n0.7\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.21\n1.97, 2.48\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.36\n1.23, 1.49\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.80, 1.03\n0.2\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute Kidney Injury:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n1.44\n1.27, 1.63\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.23\n1.12, 1.34\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.30\n1.13, 1.49\n&lt;0.001\n\n\n    Hispanic\n0.85\n0.74, 0.99\n0.031\n\n\n    Other\n1.03\n0.87, 1.21\n0.7\n\n\nAge, y\n1.02\n1.02, 1.02\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.02\n0.90, 1.15\n0.7\n\n\n    $66,000 - $87,999\n0.90\n0.79, 1.02\n0.095\n\n\n    $88,000 or more\n1.04\n0.91, 1.19\n0.5\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.00\n0.87, 1.15\n&gt;0.9\n\n\n    Medicare\n0.93\n0.83, 1.04\n0.2\n\n\n    Other\n0.90\n0.70, 1.16\n0.4\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.18\n1.06, 1.31\n0.003\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n2.53\n2.22, 2.88\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.12\n0.98, 1.29\n0.10\n\n\n    South\n1.06\n0.94, 1.19\n0.4\n\n\n    West\n0.96\n0.85, 1.10\n0.6\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.07\n0.96, 1.19\n0.2\n\n\n    Small\n0.98\n0.85, 1.12\n0.8\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.93\n0.64, 1.34\n0.7\n\n\n    Urban, teaching\n0.83\n0.60, 1.16\n0.3\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n0.78\n0.69, 0.89\n&lt;0.001\n\n\n    Acute Myeloid Leukemia\n0.50\n0.42, 0.59\n&lt;0.001\n\n\n    Chronic Lymphocytic Leukemia\n0.52\n0.43, 0.62\n&lt;0.001\n\n\n    Chronic Myeloid Leukemia\n0.50\n0.40, 0.64\n&lt;0.001\n\n\n    Multilpe Myeloma\n1.34\n1.08, 1.65\n0.007\n\n\n    Other\n0.88\n0.76, 1.02\n0.085\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.28\n1.07, 1.53\n0.007\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.92, 1.18\n0.5\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.42\n2.09, 2.80\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.83, 1.24\n&gt;0.9\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.82, 1.04\n0.2\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.39\n2.06, 2.78\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.16\n1.05, 1.27\n0.003\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.31\n1.14, 1.50\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nRenal Replacement Therapy:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n1.35\n1.15, 1.57\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.20\n1.08, 1.35\n0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.33\n1.14, 1.54\n&lt;0.001\n\n\n    Hispanic\n1.02\n0.84, 1.24\n0.8\n\n\n    Other\n1.16\n0.94, 1.43\n0.2\n\n\nAge, y\n1.00\n0.99, 1.00\n0.055\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.01\n0.87, 1.17\n0.9\n\n\n    $66,000 - $87,999\n0.95\n0.81, 1.11\n0.5\n\n\n    $88,000 or more\n1.04\n0.89, 1.22\n0.6\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.90\n0.75, 1.09\n0.3\n\n\n    Medicare\n0.84\n0.72, 0.97\n0.021\n\n\n    Other\n0.86\n0.60, 1.22\n0.4\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.30\n1.14, 1.48\n&lt;0.001\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n1.62\n1.33, 1.98\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.77\n0.65, 0.93\n0.006\n\n\n    South\n0.92\n0.80, 1.07\n0.3\n\n\n    West\n1.05\n0.89, 1.23\n0.6\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.92\n0.80, 1.05\n0.2\n\n\n    Small\n0.83\n0.70, 1.00\n0.044\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.84\n1.10, 3.09\n0.021\n\n\n    Urban, teaching\n1.65\n1.01, 2.68\n0.044\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.18\n0.98, 1.41\n0.082\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.86, 1.16\n&gt;0.9\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.90\n1.63, 2.21\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.73, 1.16\n0.5\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.85, 1.15\n0.9\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.58\n2.25, 2.96\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.29\n1.14, 1.46\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n0.93, 1.27\n0.3\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nNon-Home Discharge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n1.43\n1.28, 1.60\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.89\n0.82, 0.96\n0.004\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.20\n1.07, 1.36\n0.002\n\n\n    Hispanic\n0.80\n0.70, 0.92\n0.002\n\n\n    Other\n1.14\n0.99, 1.32\n0.071\n\n\nAge, y\n1.01\n1.01, 1.02\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.06\n0.95, 1.17\n0.3\n\n\n    $66,000 - $87,999\n0.96\n0.86, 1.07\n0.4\n\n\n    $88,000 or more\n0.96\n0.86, 1.08\n0.5\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.16\n1.01, 1.32\n0.033\n\n\n    Medicare\n1.12\n1.01, 1.24\n0.032\n\n\n    Other\n1.38\n1.10, 1.74\n0.005\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.42\n1.29, 1.56\n&lt;0.001\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n2.29\n2.01, 2.61\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.14\n1.01, 1.30\n0.037\n\n\n    South\n0.88\n0.78, 0.98\n0.023\n\n\n    West\n0.72\n0.64, 0.82\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.27\n1.15, 1.40\n&lt;0.001\n\n\n    Small\n1.15\n1.01, 1.30\n0.030\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.14\n0.84, 1.54\n0.4\n\n\n    Urban, teaching\n0.84\n0.63, 1.10\n0.2\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n0.96\n0.85, 1.07\n0.4\n\n\n    Acute Myeloid Leukemia\n0.57\n0.47, 0.69\n&lt;0.001\n\n\n    Chronic Lymphocytic Leukemia\n0.60\n0.50, 0.71\n&lt;0.001\n\n\n    Chronic Myeloid Leukemia\n0.59\n0.46, 0.74\n&lt;0.001\n\n\n    Multilpe Myeloma\n0.66\n0.55, 0.78\n&lt;0.001\n\n\n    Other\n0.99\n0.87, 1.12\n0.9\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.17\n1.02, 1.36\n0.030\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.88, 1.09\n0.7\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.88\n0.78, 0.99\n0.035\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.81, 1.12\n0.6\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.88, 1.09\n0.7\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.76\n2.45, 3.10\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.83, 0.99\n0.026\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n0.91, 1.15\n0.7\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nFluid and Electrolyte Imbalance:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n1.12\n0.99, 1.26\n0.076\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.85\n0.78, 0.93\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.19\n1.03, 1.37\n0.016\n\n\n    Hispanic\n1.11\n0.95, 1.30\n0.2\n\n\n    Other\n1.06\n0.89, 1.25\n0.5\n\n\nAge, y\n1.01\n1.00, 1.01\n0.005\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.01\n0.89, 1.14\n&gt;0.9\n\n\n    $66,000 - $87,999\n0.97\n0.86, 1.10\n0.7\n\n\n    $88,000 or more\n1.08\n0.95, 1.23\n0.3\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.91\n0.79, 1.06\n0.2\n\n\n    Medicare\n0.90\n0.80, 1.02\n0.093\n\n\n    Other\n0.89\n0.68, 1.17\n0.4\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.38\n1.23, 1.55\n&lt;0.001\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n2.19\n1.93, 2.48\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.91\n0.79, 1.05\n0.2\n\n\n    South\n0.92\n0.81, 1.04\n0.2\n\n\n    West\n0.86\n0.75, 0.99\n0.037\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.08\n0.96, 1.20\n0.2\n\n\n    Small\n1.06\n0.91, 1.24\n0.4\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.31\n0.95, 1.80\n0.10\n\n\n    Urban, teaching\n1.23\n0.92, 1.63\n0.2\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n0.62\n0.55, 0.70\n&lt;0.001\n\n\n    Acute Myeloid Leukemia\n0.45\n0.38, 0.53\n&lt;0.001\n\n\n    Chronic Lymphocytic Leukemia\n0.96\n0.78, 1.17\n0.7\n\n\n    Chronic Myeloid Leukemia\n0.51\n0.41, 0.65\n&lt;0.001\n\n\n    Multilpe Myeloma\n0.96\n0.78, 1.18\n0.7\n\n\n    Other\n0.78\n0.67, 0.91\n0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.33\n1.12, 1.58\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.15\n1.02, 1.30\n0.021\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n1.09, 1.42\n0.002\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.76, 1.13\n0.4\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.89, 1.13\n&gt;0.9\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.34\n2.01, 2.73\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.52\n1.38, 1.67\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.84, 1.09\n0.5\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nHyperkalemia:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n1.10\n0.98, 1.25\n0.10\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.15\n1.05, 1.25\n0.002\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.30\n1.15, 1.46\n&lt;0.001\n\n\n    Hispanic\n1.07\n0.92, 1.25\n0.3\n\n\n    Other\n1.00\n0.85, 1.17\n&gt;0.9\n\n\nAge, y\n1.00\n1.00, 1.01\n0.4\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.01\n0.91, 1.14\n0.8\n\n\n    $66,000 - $87,999\n0.92\n0.82, 1.03\n0.14\n\n\n    $88,000 or more\n1.04\n0.92, 1.17\n0.5\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.12\n0.97, 1.29\n0.12\n\n\n    Medicare\n0.98\n0.87, 1.09\n0.7\n\n\n    Other\n1.40\n1.09, 1.79\n0.008\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.06\n0.95, 1.17\n0.3\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n1.40\n1.21, 1.63\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.96\n0.83, 1.10\n0.6\n\n\n    South\n0.91\n0.81, 1.03\n0.13\n\n\n    West\n0.79\n0.70, 0.91\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.03\n0.93, 1.14\n0.6\n\n\n    Small\n1.08\n0.95, 1.24\n0.3\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.30\n0.94, 1.79\n0.11\n\n\n    Urban, teaching\n1.03\n0.77, 1.38\n0.8\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n0.46\n0.40, 0.53\n&lt;0.001\n\n\n    Acute Myeloid Leukemia\n0.62\n0.51, 0.76\n&lt;0.001\n\n\n    Chronic Lymphocytic Leukemia\n1.79\n1.52, 2.11\n&lt;0.001\n\n\n    Chronic Myeloid Leukemia\n0.62\n0.48, 0.81\n&lt;0.001\n\n\n    Multilpe Myeloma\n0.70\n0.59, 0.84\n&lt;0.001\n\n\n    Other\n0.71\n0.61, 0.81\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n0.98, 1.32\n0.084\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.33\n1.19, 1.48\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.42\n1.26, 1.61\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.78, 1.13\n0.5\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.89, 1.11\n&gt;0.9\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.65\n1.46, 1.85\n&lt;0.001\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.89, 1.06\n0.5\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.07\n0.95, 1.21\n0.3\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nCardiac Arrhythmia:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n2.90\n2.57, 3.27\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.37\n1.24, 1.51\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.80\n0.69, 0.93\n0.003\n\n\n    Hispanic\n0.71\n0.60, 0.85\n&lt;0.001\n\n\n    Other\n0.74\n0.61, 0.89\n0.001\n\n\nAge, y\n1.03\n1.02, 1.03\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.12\n0.98, 1.27\n0.10\n\n\n    $66,000 - $87,999\n1.10\n0.96, 1.26\n0.2\n\n\n    $88,000 or more\n1.18\n1.03, 1.35\n0.021\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.03\n0.86, 1.23\n0.8\n\n\n    Medicare\n1.29\n1.13, 1.46\n&lt;0.001\n\n\n    Other\n1.10\n0.83, 1.46\n0.5\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n1.11\n0.99, 1.25\n0.083\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n1.15\n1.00, 1.33\n0.044\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.86\n0.74, 0.99\n0.031\n\n\n    South\n0.92\n0.81, 1.04\n0.2\n\n\n    West\n0.92\n0.80, 1.06\n0.3\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.91\n0.82, 1.02\n0.11\n\n\n    Small\n0.96\n0.84, 1.11\n0.6\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.93\n0.68, 1.27\n0.6\n\n\n    Urban, teaching\n0.94\n0.71, 1.25\n0.7\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n1.06\n0.92, 1.21\n0.4\n\n\n    Acute Myeloid Leukemia\n1.03\n0.83, 1.28\n0.8\n\n\n    Chronic Lymphocytic Leukemia\n1.15\n0.96, 1.38\n0.13\n\n\n    Chronic Myeloid Leukemia\n1.09\n0.84, 1.42\n0.5\n\n\n    Multilpe Myeloma\n1.25\n1.04, 1.50\n0.015\n\n\n    Other\n0.98\n0.84, 1.14\n0.8\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n0.89, 1.23\n0.6\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.90, 1.15\n0.8\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.08\n0.95, 1.23\n0.2\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.33\n1.10, 1.59\n0.002\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.17\n1.04, 1.32\n0.008\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.12\n0.98, 1.28\n0.11\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n1.03, 1.26\n0.011\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.04\n0.92, 1.19\n0.5\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of Heart Failure on In-Hospital Outcomes in Tumor Lysis Syndrome: A National Inpatient Sample Analysis",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n2.6\n1.8, 3.3\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n-0.51\n-1.1, 0.04\n0.067\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.52\n-0.23, 1.3\n0.2\n\n\n    Hispanic\n1.5\n0.46, 2.5\n0.004\n\n\n    Other\n1.1\n0.01, 2.3\n0.047\n\n\nAge, y\n-0.13\n-0.15, -0.10\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.13\n-0.85, 0.60\n0.7\n\n\n    $66,000 - $87,999\n0.19\n-0.57, 0.95\n0.6\n\n\n    $88,000 or more\n0.25\n-0.53, 1.0\n0.5\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.54\n-0.57, 1.6\n0.3\n\n\n    Medicare\n-0.50\n-1.2, 0.25\n0.2\n\n\n    Other\n0.30\n-1.4, 2.0\n0.7\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n0.57\n-0.09, 1.2\n0.090\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n0.05\n-0.80, 0.89\n&gt;0.9\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n2.0\n1.1, 2.9\n&lt;0.001\n\n\n    South\n0.21\n-0.53, 0.96\n0.6\n\n\n    West\n0.78\n-0.18, 1.7\n0.11\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-1.8\n-2.6, -1.0\n&lt;0.001\n\n\n    Small\n-2.8\n-3.6, -2.0\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.9\n0.57, 3.3\n0.005\n\n\n    Urban, teaching\n4.0\n2.9, 5.2\n&lt;0.001\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n5.0\n4.1, 6.0\n&lt;0.001\n\n\n    Acute Myeloid Leukemia\n3.9\n2.5, 5.2\n&lt;0.001\n\n\n    Chronic Lymphocytic Leukemia\n-2.3\n-3.1, -1.5\n&lt;0.001\n\n\n    Chronic Myeloid Leukemia\n-1.6\n-3.2, 0.10\n0.066\n\n\n    Multilpe Myeloma\n-1.0\n-2.0, -0.12\n0.026\n\n\n    Other\n1.4\n0.58, 2.3\n0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.4\n0.61, 2.3\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.21\n-0.85, 0.43\n0.5\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.2\n-1.9, -0.49\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.2\n-2.2, -0.23\n0.016\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.43\n-1.1, 0.21\n0.2\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.32\n-1.1, 0.41\n0.4\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5.7\n5.2, 6.2\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.44\n-0.26, 1.1\n0.2\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nTotal hospital charges:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nPatients with tumor lysis syndrome\n\n\n\n\n\n\n\n\n    Without heart failure\n—\n—\n\n\n\n\n    With heart failure\n64,972\n40,109, 89,835\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1,039\n-14,350, 16,428\n0.9\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n-6,183\n-24,575, 12,210\n0.5\n\n\n    Hispanic\n42,605\n16,308, 68,902\n0.002\n\n\n    Other\n35,414\n1,889, 68,939\n0.038\n\n\nAge, y\n-3,514\n-4,436, -2,593\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n11,007\n-8,405, 30,419\n0.3\n\n\n    $66,000 - $87,999\n3,382\n-15,482, 22,246\n0.7\n\n\n    $88,000 or more\n14,980\n-5,573, 35,534\n0.2\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-6,608\n-36,914, 23,699\n0.7\n\n\n    Medicare\n3,522\n-17,102, 24,145\n0.7\n\n\n    Other\n-11,555\n-59,627, 36,517\n0.6\n\n\nWeekend Admission\n\n\n\n\n\n\n\n\n    Monday-Friday\n—\n—\n\n\n\n\n    Saturday-Sunday\n9,921\n-5,156, 24,998\n0.2\n\n\nType of admission\n\n\n\n\n\n\n\n\n    Elective\n—\n—\n\n\n\n\n    Non-elective\n-35,111\n-71,152, 931\n0.056\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n87,599\n50,705, 124,493\n&lt;0.001\n\n\n    South\n-2,516\n-23,110, 18,079\n0.8\n\n\n    West\n98,819\n59,746, 137,893\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-43,988\n-70,222, -17,755\n0.001\n\n\n    Small\n-83,230\n-102,998, -63,462\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n70,544\n43,464, 97,624\n&lt;0.001\n\n\n    Urban, teaching\n121,942\n98,386, 145,499\n&lt;0.001\n\n\nType of Cancer\n\n\n\n\n\n\n\n\n    Solid Tumors\n—\n—\n\n\n\n\n    Acute Lymphoblastic Leukemia\n58,409\n31,931, 84,888\n&lt;0.001\n\n\n    Acute Myeloid Leukemia\n43,268\n6,545, 79,991\n0.021\n\n\n    Chronic Lymphocytic Leukemia\n-52,343\n-73,862, -30,825\n&lt;0.001\n\n\n    Chronic Myeloid Leukemia\n-53,036\n-96,757, -9,315\n0.017\n\n\n    Multilpe Myeloma\n-48,528\n-73,532, -23,523\n&lt;0.001\n\n\n    Other\n10,062\n-11,034, 31,159\n0.3\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n30,749\n10,825, 50,672\n0.002\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-16,133\n-30,820, -1,446\n0.031\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-44,005\n-62,930, -25,079\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-29,906\n-51,000, -8,812\n0.005\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-14,119\n-30,513, 2,276\n0.091\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n29,006\n7,966, 50,047\n0.007\n\n\nAnemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n118,095\n102,022, 134,168\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1,184\n-16,113, 18,481\n0.9\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]